(Q35675497)

9 August 2017

1 reference

title

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes (English)

1 reference

9 August 2017

0 references

Andrew J Krentz

1

1 reference

PubMed ID

14984018

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Diabetes, Obesity and Metabolism

9 August 2017

1 reference

9 August 2017

5 Suppl 1

1 reference

9 August 2017

S19-27

1 reference

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

UKPDS and beyond: into the next millennium. United Kingdom Prospective Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

The assessment of insulin resistance in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

The fourth musketeer--from Alexandre Dumas to Claude Bernard

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Mobilisation of triacylglycerol stores

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Postprandial lipoprotein metabolism and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Therapeutic considerations for postprandial dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Statins do more than just lower cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Antiatherogenic effects of thiazolidinediones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2003.0310.X

10.1046/J.1462-8902.2003.0310.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14984018